Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Blue Light Intraocular Lenses (IOLs) and Photostress

This study has been completed.
Sponsor:
Information provided by:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00710996
First received: July 3, 2008
Last updated: January 29, 2010
Last verified: January 2010
  Purpose

To determine what effect a blue light filtering Intraocular Lens (IOL) has on macular pigment levels.


Condition
Cataract

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Blue Light Intraocular Lenses (IOLs) and Photostress

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • Photostress Recovery Time in Seconds. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 58
Study Start Date: January 2008
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
AcrySof Natural Intraocular Lens
AcrySof Natural Intraocular Lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SN"
AcrySof clear intraocular lens
AcrySof clear intraocular lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SA"
Phakic patients
Phakic patients - Age matched patients who have not had cataract surgery

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients with existing bilateral Intraocular Lenses (IOLs) of given type, age-matched patients with normal vision and no cataract surgery.

Criteria

Inclusion Criteria:

  • Patients with existing bilateral IOLs of given type, age-matched patients with normal vision and no cataract surgery.

Exclusion Criteria:

  • Age related
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00710996

Locations
United States, Texas
Call Alcon Call Center for Study Locations
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
  More Information

No publications provided by Alcon Research

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Rick Potvin, Alcon Laboratories, Inc.
ClinicalTrials.gov Identifier: NCT00710996     History of Changes
Other Study ID Numbers: M07-023
Study First Received: July 3, 2008
Results First Received: September 18, 2009
Last Updated: January 29, 2010
Health Authority: United States: Food and Drug Administration

Keywords provided by Alcon Research:
AcrySof IQ IOL

ClinicalTrials.gov processed this record on November 20, 2014